Clearmind patent publication covers Japan treatment for dyskinesia
Clearmind Medicine said a Japan patent application was published covering a 3-MMC-based treatment for dyskinesia, including combinations with palmitoylethanolamide (PEA).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.